Brief: Eurocine Vaccines Gets Authorized To Conduct Phase I/II Clinical Study

Nidhogg Resources Holding AB (publ)

11/01/2018 14:53

Jan 11 (Reuters) - EUROCINE VACCINES AB  EUCI.TE : 
    * EUROCINE VACCINES OBTAINS AUTHORIZATION TO CONDUCT THE 
NEXT 
STUDY WITH IMMUNOSE FLU 
    * GOT AUTHORIZATION TO CONDUCT A PHASE I/II CLINICAL STUDY 
ON 
QUADRIVALENT INFLUENZA VACCINE CANDIDATE IMMUNOSE FLU 
    * RESULTS CAN BE EXPECTED SECOND HALF OF 2018. 
    * AUTHORIZATIONS TO CONDUCT STUDY RECEIVED FROM SWEDISH 
MEDICAL 
PRODUCTS AGENCY AND ETHICS COMMITTEE 
 
Source text for Eikon:  ID:nWkr1ZNgs5  
Further company coverage:  EUCI.TE  
 
 (Gdynia Newsroom) 
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))